United Kingdom

The United Kingdom is represented in JPIAMR by the Medical Research Council (MRC).

The MRC is a publicly-funded organisation dedicated to improving human health. Research into combating antimicrobial resistance remains a priority to MRC and is currently funded by response-mode grants, fellowships and strategic initiatives.

National AMR research program and activities

AMR Research program

  • UKRI AMR Initiative; launched 2014
  • Global AMR Innovation Fund (GAMRIF); launched 2016
  • Fleming Fund; launched 2016
  • National PhD Training Programme in AMR; Medical Research Foundation (MRF)
  • AMR Structured Operational Research and Training Initiative (AMR SORT IT); January 2019 – December 2022 NIHR with UNICEF/UNDP/ World Bank/ WHO
  • UK Food Standards Agency AMR Programme

National AMR research calls

  • China-UK AMR Partnership Hubs 2018; March 2018; MRC/UKRI; academic led
  • UK-China collaboration to tackle AMR; April 2018; Innovate/GAMRIF; industry led
  • JPIAMR Surveillance network call; launched May 2018; MRC for UK-led networks
  • JPIAMR VRI network call; launched May 2018; MRC for UK-led networks
  • Review of the impact of food processing on AMR in meat & meat products; FSA June 2018
  • Burden of antimicrobial resistance genes in selected ready-to-eat foods; FSA August 2018
  • Capital call to support AMR research; NIHR October 2018
  • BBSRC/NERC-CONICET Joint Awards for AMR in the Environment; launched November 1st 2018
  • Health Protection Research Unit in healthcare associated infections and AMR; NIHR March 2019
  • UK-India tackling AMR in the environment from antimicrobial manufacturing waste; May 2019
  • UK-South Africa AMR Drug Discovery Hub call; June 2019

Activities on AMR actions at national level

  • AMR Research to Policy Workshop; July 2018 London UK
  • Annual AMR Residential PhD Training course
  • AMR Call to Action Summit; November 2018 Accra Ghana
  • AMR Panel Event in Parliament; February 2019
  • Tackling AMR National Campaign; March 2019
  • UK-India tackling AMR in the environment from antimicrobial manufacturing waste; May 2019
  • UK-South Africa AMR Drug Discovery Workshop; June 2019
  • UK antibiotic procurement model launched June 2020
  • Acquired carbapenemase-producing Gram-negative bacteria added to the list of organisms in the UK requiring statutory notification (July 2020).
  • UK AMR Public Consultation – Webinar series Sept 2020

National action plans

Management Board representative

  • Stephen Boname, UKRI Medical Research Council
  • Jonathan Oakeshott, UKRI Medical Research Council